Efficacy and Safety of Oral Erlotinib in TRPV3-related Olmsted Syndrome: a Case Series
Authors:
- 3 July 2025
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China